Global Antibody Drug Conjugates Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 12.9% - ResearchAndMarkets.com

June 6, 2018

DUBLIN--(BUSINESS WIRE)--Jun 6, 2018--The “Antibody Drug Conjugates Market by Drugs - Global Opportunity Analysis and Industry Forecast 2017-2023.” report has been added to ResearchAndMarkets.com’s offering.

The antibody drug conjugates market was valued at $1,387 million in 2016, and is estimated to reach $3,198 million by 2023, registering a CAGR of 12.9% from 2017 to 2023.

Increase in global prevalence of cancer and demand for quality & cost-effective cancer medications drives the global ADCs market. In addition, extensive R&D for cancer medication and approval of new cancer drugs is expected to boost the market growth during the forecast period. However, high cost involved in R&D of cancer medication and stringent government regulations impedes the growth of antibody drug conjugates market.

The report segments the market based on drugs, mechanism of action, application, and region. Based on drugs, the market is bifurcated into Adcetris and Kadcyla. Based on mechanism of action, it is divided into CD30 antibodies and HER2 antibodies. Based on application, the market is classified into breast cancer, lymphoma, and others.

Companies Mentioned:

F. Hoffman-La Roche Ltd. Novartis AG Takeda Pharmaceutical Company Limited Pfizer, Inc. Seattle Genetics Inc. Genentech Inc. Immunogen Inc. Immunomedics, Inc. Progenics Pharmaceuticals Inc. Bayer AG

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Global Antibody Drug Conjugates Market, By Drugs

Chapter 5 Global Antibody Drug Conjugates Market, By Mechanism Of Action

Chapter 6 Global Antibody Drug Conjugates Market, By Application

Chapter 7 Global Antibody Drug Conjugates Market, By Geography

Chapter 8 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/9hfn5k/global_antibody?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180606005512/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/06/2018 04:54 AM/DISC: 06/06/2018 04:54 AM


Update hourly